ROCKVILLE, Md., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T cell therapies for liquid and solid tumors,today announced the appointment of Christopher Ballas, Ph.D., as Senior Vice President of Manufacturing.
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc.
Funding to Support Ongoing Advancement of siFi2, Lead Candidate from Companys First-of-its-Kind Platform for Precisely Controlling Core Cell Migration Mechanisms NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the bodys innate regenerative mechanisms to accelerate tissue repair, today announced that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The two-year, $1.5 million award will support ongoing development of the companys lead product candidate, siFi2.
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024. Report Scope: The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries.
Investment Thesis The investment thesis of this article is that the most important reason for investing in any stock is its potential for portfolio wealth-building. That requires informed forecasts of its likely future price
Spectators exclaimed in horror at the 2018 MotoGP Asia Talent Cup race when Danial Syahmi Sharil almost lost his life in a serious accident. The 16-year-old rising star had a terrifying collision that saw him thrown off his motorcycle and then run over by a fellow racer on the Sepang International Circuit that November, suffering serious injuries in his lower left leg
For its promising investigational therapeutic approach to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), BrainStorm Cell Therapeutics is theBuzz of BIO 2020 winnerin the Public Therapeutic Biotech category. The Buzz of BIO contest identifies U.S.
NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029 Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN Key Questions Answered in this Report: What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
Updated January 06, 2020 08:30:20 Since being diagnosed with Hodgkin's lymphoma 18 months ago, Aliona Grytsenko has spent much of her time in and out of hospital.
Recent Comments